| Code | 3691D | ||||||||||
| MA number | EU/1/19/1417/001 | ||||||||||
| Product Form: | sol inj 1x0,165 ml/19,8 mg (striek.inj.napl.skl.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| Therapeutic Class: | 64 - OPHTHALMOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Intravitreal use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 13.02.2020 |
| Validity: | 13.02.2025 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
Beovu_Príručka pre pacienta.pdf
|
| Dokument: |
Beovu_Váš sprievodca liečbou Beovu_audionahravka.mp3
|
| Safety feature | Yes |
| Data update: | 20.08.2021 |
